| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ono-2506 | adrenergic receptor beta-3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cessation of life[MeSHID:D003643] Cerebrovascular accident[MeSHID:D020521] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Expiration function[MeSHID:D045853] |
NA | phase 2/3 | unknown |
| ono-2506 | s100 calcium-binding protein b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cessation of life[MeSHID:D003643] Cerebrovascular accident[MeSHID:D020521] Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Expiration function[MeSHID:D045853] |
NA | phase 2/3 | unknown |
| click here to return to the previous page | ||||||||